Loss of HLA molecules in B lymphomas is associated with an aggressive clinical course (Q74412176)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9531330 AND SRC:MED&resulttype=core&format=json

10 November 2019

title

Loss of HLA molecules in B lymphomas is associated with an aggressive clinical course (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9531330 AND SRC:MED&resulttype=core&format=json

10 November 2019

author name string

L. Amiot

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9531330

15 December 2024

M. Onno

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9531330

15 December 2024

T. Lamy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9531330

15 December 2024

C. Dauriac

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9531330

15 December 2024

P. Y. Le Prise

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9531330

15 December 2024

R. Fauchet

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9531330

15 December 2024

B. Drenou

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9531330

15 December 2024

language of work or name

English

0 references

publication date

1 March 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9531330 AND SRC:MED&resulttype=core&format=json

10 November 2019

March 1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9531330

full work available at URL

15 December 2024

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2141.1998.00631.x

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9531330

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046/j.1365-2141.1998.00631.x

15 December 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2141.1998.00631.x

15 December 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

British Journal of Haematology

15 December 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9531330 AND SRC:MED&resulttype=core&format=json

10 November 2019

volume

100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9531330 AND SRC:MED&resulttype=core&format=json

10 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9531330 AND SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

655-663

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9531330 AND SRC:MED&resulttype=core&format=json

Distribution of HLA-G alternative mRNAs including soluble forms in normal lymphocytes and in lymphoid cell-derived leukemia

10 November 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis

15 December 2024

2

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors

15 December 2024

3

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

High frequency of altered HLA class I phenotypes in invasive breast carcinomas

15 December 2024

4

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer

15 December 2024

5

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.

15 December 2024

6

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

Quantitative expression of HLA class I molecules in acute non-lymphoblastic leukaemia cells

15 December 2024

7

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

Deficient expression of class-I HLA in some cases of acute leukemia

15 December 2024

9

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

15 December 2024

10

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

Natural history of HLA expression during tumour development.

15 December 2024

12

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA

15 December 2024

13

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

15 December 2024

15

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer

15 December 2024

16

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

Natural killer cells: from no receptors to too many

15 December 2024

18

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association

15 December 2024

19

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

MHC Class I Deficiency: Susceptibility to Natural Killer (NK) Cells and Impaired NK Activity

15 December 2024

21

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

Induction of MHC class I expression by the MHC class II transactivator CIITA.

15 December 2024

23

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma

15 December 2024

25

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

Defective expression of MHC class I antigens is frequent in B-cell lymphomas of high-grade malignancy

15 December 2024

26

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

B-cell lymphomas of high-grade malignancy frequently lack HLA-DR, -DP and -DQ antigens and associated invariant chain.

15 December 2024

27

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells

15 December 2024

28

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes

15 December 2024

29

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex

15 December 2024

30

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genes

15 December 2024

32

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

Loss of surface HLA class I molecules in leukemic myeloblasts is correlated with an increased leukocyte concentration at onset

15 December 2024

34

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy

15 December 2024

39

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

15 December 2024

41

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

Lymphocyte programmed cell death is mediated via HLA class II DR.

15 December 2024

43

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

Ligation of HLA class II molecules promotes sensitivity to CD95 (Fas antigen, APO-1)-mediated apoptosis

15 December 2024

46

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.1998.00631.X

15 December 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9531330 AND SRC:MED&resulttype=core&format=json

10 November 2019

1 reference